These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 10351899)

  • 1. Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells.
    Kran AM; Sørensen B; Sommerfelt MA; Nyhus J; Baksaas I; Kvale D
    AIDS; 2006 Feb; 20(4):627-30. PubMed ID: 16470131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells.
    Azzoni L; Chehimi J; Zhou L; Foulkes AS; June R; Maino VC; Landay A; Rinaldo C; Jacobson LP; Montaner LJ
    AIDS; 2007 Jan; 21(3):293-305. PubMed ID: 17255736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine based on dendritic cells.
    AIDS Patient Care STDS; 1999 Apr; 13(4):249. PubMed ID: 10351899
    [No Abstract]   [Full Text] [Related]  

  • 4. Natural killer cells, dendritic cells, and the alarmin high-mobility group box 1 protein: a dangerous trio in HIV-1 infection?
    Gougeon ML; Bras M
    Curr Opin HIV AIDS; 2011 Sep; 6(5):364-72. PubMed ID: 21825870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immunity in the control of HIV/AIDS: recent advances and open questions.
    Ploquin MJ; Jacquelin B; Jochems SP; Barré-Sinoussi F; Müller-Trutwin MC
    AIDS; 2012 Jun; 26(10):1269-79. PubMed ID: 22472855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell function in HIV-1 infected patients.
    Fortis C; Tasca S; Capiluppi B; Tambussi G
    J Biol Regul Homeost Agents; 2002; 16(1):30-2. PubMed ID: 12003170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV/dendritic cell interaction: consequences in the pathogenesis of HIV infection.
    Barroca P; Calado M; Azevedo-Pereira JM
    AIDS Rev; 2014; 16(4):223-35. PubMed ID: 25350531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines.
    Ahlers JD; Belyakov IM
    Trends Mol Med; 2009 Jun; 15(6):263-74. PubMed ID: 19487159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Licensing of killer dendritic cells in mouse and humans: functional similarities between IKDC and human blood γδ T-lymphocytes.
    Anderson J; Gustafsson K; Himoudi N
    J Immunotoxicol; 2012; 9(3):259-66. PubMed ID: 22632132
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.